Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
Nearly 60 MIT faculty members have volunteered to donate their time and expertise to raise money to support Cambridge residents via the Cambridge Mayor’s Disaster Relief Fund for Covid-19 and the Cambridge Community Foundation's Cambridge Covid-19 Emergency Fund. The MIT community and beyond can bid on a lunch conversation (via Zoom or in-person post social-distancing) with participating faculty members.